• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病对健康成年人睡眠呼吸暂停的影响:一项来自韩国的全国性研究。

The impact of non-alcoholic fatty liver disease on sleep apnea in healthy adults: A nationwide study of Korea.

机构信息

Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.

Department of Cardiology in Internal Medicine, School of Medicine, Chungnam National University Sejong Hospital, Chungnam National University, Sejong, Korea.

出版信息

PLoS One. 2022 Jul 20;17(7):e0271021. doi: 10.1371/journal.pone.0271021. eCollection 2022.

DOI:10.1371/journal.pone.0271021
PMID:35857770
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9299300/
Abstract

BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) is one of the most common health problems worldwide. Sleep apnea (SA) causes cardiovascular and metabolic problems, as well as a significant socioeconomic burden. Although several studies have found that SA causes NAFLD, there is no evidence that NAFLD causes SA. The goal of this study was to look at the relationship between NAFLD and SA in realworld data.

METHODS

We evaluated 334,334 healthy individuals without comorbidities who underwent National Health checkups in the Republic of Korea from 2009 to 2014. NAFLD was defined by a surrogate marker, the fatty liver index (FLI). The association between FLI and SA was analyzed using multivariate Cox proportional hazards regression models.

RESULTS

During a median followup of 5.3 years, 1,351 patients (0.4%) were newly diagnosed with SA. Subjects were categorized into quartile groups according to FLI (range: Q1, 0-4.9; Q2, 5.0-12.5; Q3, 12.6-31.0; Q4, >31.0). Subjects with higher FLIs had a significantly higher cumulative incidence of SA than those with lower FLIs (Q1, 119 [0.1%]; Q2, 210 [0.3%]; Q3, 339 [0.4%]; Q4, 683 [0.8%]; P < 0.001). Adjusted hazard ratios (HRs) revealed that a higher FLI was independently associated with an increased risk of SA (HR between Q4 and Q1, 4.03; 95% confidence interval, 3.22-5.05; P < 0.001). This association remained statistically significant after further adjustment for Body mass index (BMI) (HR between Q4 and Q1, 2.19; 95% confidence interval, 1.69-2.83; P < 0.001). FLI was significantly associated with an increased risk of new-onset SA regardless of baseline characteristics.

CONCLUSION

This study demonstrated that NAFLD, assessed by FLI, was independently associated with increased risk for SA in the healthy Korean population.

摘要

背景与目的

非酒精性脂肪性肝病(NAFLD)是全球最常见的健康问题之一。睡眠呼吸暂停(SA)会导致心血管和代谢问题,以及显著的社会经济负担。尽管有几项研究发现 SA 会导致 NAFLD,但没有证据表明 NAFLD 会导致 SA。本研究旨在观察真实世界数据中 NAFLD 与 SA 之间的关系。

方法

我们评估了 2009 年至 2014 年期间在大韩民国接受国家健康检查的 334334 名无合并症的健康个体。NAFLD 由替代标志物——脂肪肝指数(FLI)定义。使用多变量 Cox 比例风险回归模型分析 FLI 与 SA 之间的关联。

结果

在中位随访 5.3 年期间,有 1351 例(0.4%)患者新诊断为 SA。根据 FLI 将受试者分为四分位组(范围:Q1,0-4.9;Q2,5.0-12.5;Q3,12.6-31.0;Q4,>31.0)。FLI 较高的受试者发生 SA 的累积发生率明显高于 FLI 较低的受试者(Q1,119 [0.1%];Q2,210 [0.3%];Q3,339 [0.4%];Q4,683 [0.8%];P<0.001)。调整后的危险比(HR)显示,较高的 FLI 与 SA 风险增加独立相关(Q4 与 Q1 相比,HR 为 4.03;95%置信区间,3.22-5.05;P<0.001)。进一步调整体重指数(BMI)后,这种关联仍然具有统计学意义(Q4 与 Q1 相比,HR 为 2.19;95%置信区间,1.69-2.83;P<0.001)。无论基线特征如何,FLI 均与新发 SA 的风险增加显著相关。

结论

本研究表明,在健康的韩国人群中,通过 FLI 评估的 NAFLD 与 SA 风险增加独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bcf/9299300/da9a93683af6/pone.0271021.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bcf/9299300/30c89034a3cc/pone.0271021.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bcf/9299300/d8da0161a107/pone.0271021.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bcf/9299300/da9a93683af6/pone.0271021.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bcf/9299300/30c89034a3cc/pone.0271021.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bcf/9299300/d8da0161a107/pone.0271021.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bcf/9299300/da9a93683af6/pone.0271021.g003.jpg

相似文献

1
The impact of non-alcoholic fatty liver disease on sleep apnea in healthy adults: A nationwide study of Korea.非酒精性脂肪性肝病对健康成年人睡眠呼吸暂停的影响:一项来自韩国的全国性研究。
PLoS One. 2022 Jul 20;17(7):e0271021. doi: 10.1371/journal.pone.0271021. eCollection 2022.
2
Association between non-alcoholic fatty liver disease and risk of new-onset atrial fibrillation in healthy adults.健康成年人中非酒精性脂肪性肝病与新发心房颤动风险之间的关联。
Liver Int. 2020 Feb;40(2):338-346. doi: 10.1111/liv.14236. Epub 2019 Sep 22.
3
Higher fatty liver index is associated with increased risk of new onset heart failure in healthy adults: a nationwide population-based study in Korea.高脂肪肝指数与健康成年人新发心力衰竭风险增加相关:一项来自韩国的全国基于人群的研究。
BMC Cardiovasc Disord. 2020 Apr 28;20(1):204. doi: 10.1186/s12872-020-01444-x.
4
Association between nonalcoholic fatty liver disease and cardiovascular disease revealed after comprehensive control of metabolic risk factors: a nationwide population-based study in Korea.非酒精性脂肪肝疾病与心血管疾病之间的关联在综合控制代谢风险因素后显现:一项来自韩国的全国范围内基于人群的研究。
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e375-e382. doi: 10.1097/MEG.0000000000002102.
5
Association of nonalcoholic fatty liver disease and venous thromboembolic disease in healthy adults in Korea: a nationwide study.韩国健康成年人中非酒精性脂肪肝疾病与静脉血栓栓塞性疾病的相关性:一项全国性研究。
Sci Rep. 2023 Sep 26;13(1):16069. doi: 10.1038/s41598-023-42963-9.
6
A Close Relationship between Non-Alcoholic Fatty Liver Disease Marker and New-Onset Hypertension in Healthy Korean Adults.韩国健康成年人非酒精性脂肪性肝病标志物与新发高血压之间的密切关系。
Korean Circ J. 2020 Aug;50(8):695-705. doi: 10.4070/kcj.2019.0379. Epub 2020 Mar 23.
7
Relationship between the High Fatty Liver Index and Risk of Fracture.高脂性脂肪肝指数与骨折风险的关系。
Gut Liver. 2023 Jan 15;17(1):119-129. doi: 10.5009/gnl210571. Epub 2022 Jul 27.
8
Association Between Fatty Liver Index and Risk of Breast Cancer: A Nationwide Population-Based Study.脂肪肝指数与乳腺癌风险的关联:一项全国性基于人群的研究。
Clin Breast Cancer. 2020 Aug;20(4):e450-e457. doi: 10.1016/j.clbc.2020.02.004. Epub 2020 Feb 22.
9
A nationwide survey of the association between nonalcoholic fatty liver disease and the incidence of asthma in Korean adults.一项针对韩国成年人非酒精性脂肪性肝病与哮喘发病率之间关联的全国性调查。
PLoS One. 2022 Jan 21;17(1):e0262715. doi: 10.1371/journal.pone.0262715. eCollection 2022.
10
Nonalcoholic fatty liver disease is associated with the development of obstructive sleep apnea.非酒精性脂肪性肝病与阻塞性睡眠呼吸暂停的发生有关。
Sci Rep. 2021 Jun 29;11(1):13473. doi: 10.1038/s41598-021-92703-0.

引用本文的文献

1
The association of fatty liver index and metabolic syndrome with cardiovascular outcomes, liver-related mortality, and all-cause mortality: a nationwide cohort study.脂肪肝指数和代谢综合征与心血管结局、肝脏相关死亡率及全因死亡率的关联:一项全国性队列研究
Intern Emerg Med. 2025 Jan;20(1):105-117. doi: 10.1007/s11739-024-03758-6. Epub 2024 Sep 5.
2
Fatty liver index (FLI): more than a marker of hepatic steatosis.脂肪肝指数(FLI):不仅仅是肝脂肪变性的标志物。
J Physiol Biochem. 2024 Feb;80(1):11-26. doi: 10.1007/s13105-023-00991-z. Epub 2023 Oct 25.
3
Management of non-alcoholic fatty liver disease patients with sleep apnea syndrome.

本文引用的文献

1
A nationwide survey of the association between nonalcoholic fatty liver disease and the incidence of asthma in Korean adults.一项针对韩国成年人非酒精性脂肪性肝病与哮喘发病率之间关联的全国性调查。
PLoS One. 2022 Jan 21;17(1):e0262715. doi: 10.1371/journal.pone.0262715. eCollection 2022.
2
Neurocognitive Performance Improvement after Obstructive Sleep Apnea Treatment: State of the Art.阻塞性睡眠呼吸暂停治疗后神经认知功能的改善:最新进展
Behav Sci (Basel). 2021 Dec 16;11(12):180. doi: 10.3390/bs11120180.
3
Oxidative Stress and Inflammation Biomarker Expression in Obstructive Sleep Apnea Patients.
非酒精性脂肪性肝病合并睡眠呼吸暂停综合征患者的管理。
World J Gastroenterol. 2022 Nov 21;28(43):6099-6108. doi: 10.3748/wjg.v28.i43.6099.
阻塞性睡眠呼吸暂停患者氧化应激与炎症生物标志物表达
J Clin Med. 2021 Jan 13;10(2):277. doi: 10.3390/jcm10020277.
4
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病相关肝细胞癌的全球流行病学:趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2021 Apr;18(4):223-238. doi: 10.1038/s41575-020-00381-6. Epub 2020 Dec 21.
5
Continuous Positive Airway Pressure Does Not Improve Nonalcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea. A Randomized Clinical Trial.持续气道正压通气对合并阻塞性睡眠呼吸暂停的非酒精性脂肪性肝病患者无改善作用:一项随机临床试验。
Am J Respir Crit Care Med. 2021 Feb 15;203(4):493-501. doi: 10.1164/rccm.202005-1868OC.
6
Obstructive sleep apnea and severity of nonalcoholic fatty liver disease.阻塞性睡眠呼吸暂停与非酒精性脂肪性肝病的严重程度。
Eur J Gastroenterol Hepatol. 2021 Aug 1;33(8):1104-1109. doi: 10.1097/MEG.0000000000001920.
7
Obstructive sleep apnea, depression and cognitive impairment.阻塞性睡眠呼吸暂停、抑郁症与认知障碍。
Sleep Med. 2020 Aug;72:50-58. doi: 10.1016/j.sleep.2020.03.017. Epub 2020 Mar 23.
8
Association between non-alcoholic fatty liver disease and obstructive sleep apnea.非酒精性脂肪性肝病与阻塞性睡眠呼吸暂停的关系。
World J Gastroenterol. 2020 May 28;26(20):2669-2681. doi: 10.3748/wjg.v26.i20.2669.
9
Non-alcoholic fatty liver disease among patients with sleep disorders: a Nationwide study of Taiwan.睡眠障碍患者中的非酒精性脂肪性肝病:一项台湾地区的全国性研究。
BMC Gastroenterol. 2020 Feb 10;20(1):32. doi: 10.1186/s12876-020-1178-7.
10
Obstructive sleep apnea and liver injury in severely obese patients with nonalcoholic fatty liver disease.阻塞性睡眠呼吸暂停与非酒精性脂肪性肝病重度肥胖患者的肝损伤。
Sleep Breath. 2020 Dec;24(4):1515-1521. doi: 10.1007/s11325-020-02018-z. Epub 2020 Jan 30.